FUKUI, Japan - Japanese authorities on Monday began an on-site inspection of a drugmaker based in central Japan whose antifungal medication, found to be tainted with a sleep-inducing component, is suspected of causing the death of two people in November and earlier this month.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
